BRAIN Biotech AG | Financial Results 9M 2022 / 23 | Journey to Sustainability & Prosperity with CFO

BRAIN Biotech AG: 9M 2022-23 Financial Overview IntroductionMichael Schneiders, CFO of BRAIN Biotech AG, presents an in-depth look at the company's financial performance and strategic goals, underscoring their legacy in industrial biotechnology and commitment to sustainability. Company Legacy and Achievements Established Credibility: With over 30 years in industrial biotechnology, BRAIN Biotech boasts 535 B2B products and more than 150 industrial partnerships. The company has been listed on the Frankfurt Stock Exchange since 2016. Sustainable Innovation: They aim to combine economic success with sustainable practices, achieving approximately €50 million in revenue while employing around 330 specialists. Contributions to Sustainability Food Security: Development of natural preservatives, sugar substitutes, and plant-based proteins. Health Sector Innovations: Advances in salt reduction, active pharmaceutical ingredients, and enzymatic wound care. Sustainable Industrialization: Initiatives include urban mining and using CO2 as a feedstock. Technological Advancements Genome Engineering: Focus on discovering and optimizing natural proteins and enzymes for commercial use, involving microbial strain development and rigorous optimization. Caribbean Genomics: Their genomic platform has generated significant licensing revenues, particularly in the pharmaceutical sector. Financial Performance Growth Metrics: Despite high inflation and challenges such as equipment issues at their Cardiff facility, BRAIN Biotech achieved a 12.3% growth in the first nine months. Future Sales Target: The company aims for group sales between €54 million and €57 million, demonstrating confidence in reaching mid-term objectives. Investor EngagementMichael invites potential investors to join BRAIN Biotech's vision, emphasizing opportunities in the biological revolution for sustainable solutions in nutrition, health, and the environment. The company is on a clear path to profitability and aims to establish itself among the top global players in biotech. Other Videos: Elevator Pitch Company Presentation Deep Dive Presentation Financial Results Presentation Terms & ConditionsThis publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined at Legal and Imprint.